Home/Filings/4/0001104659-23-096618
4//SEC Filing

Liawatidewi Yakob 4

Accession 0001104659-23-096618

CIK 0001297184other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 6:54 PM ET

Size

17.3 KB

Accession

0001104659-23-096618

Insider Transaction Report

Form 4
Period: 2023-08-28
Liawatidewi Yakob
DirectorEVP CORP ADMIN CENTER
Transactions
  • Sale

    Common Stock

    2023-08-28$53.13/sh28,816$1,530,99469,669 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-08-285,4970 total
    Exercise: $20.23Exp: 2029-03-15Common Stock (5,497 underlying)
  • Exercise/Conversion

    Common Stock

    2023-08-28$16.96/sh+3,319$56,29072,988 total
  • Exercise/Conversion

    Common Stock

    2023-08-28$20.23/sh+5,497$111,20478,485 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-08-283,3190 total
    Exercise: $16.96Exp: 2028-06-14Common Stock (3,319 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-08-2820,00016,176 total
    Exercise: $13.03Exp: 2030-03-16Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-08-28$13.03/sh+20,000$260,60098,485 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,459
Footnotes (5)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.87 to $53.74, inclusive.The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F3]The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
  • [F4]Shares subject to the option are fully vested and immediately exercisable.
  • [F5]Shares subject to the option vest in four equal annual installments beginning on March 16, 2021.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001743927

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:54 PM ET
Size
17.3 KB